Tweaked the format of the comparison and added Race Oncology....
CHM has more therapies, more FDA INDs, more active clinical trials and is targeting markets that are multiples of its ASX peers.....this is crazy!
CHM can therefore go 20-30X just to be comparable to its peers (excluding impact of options / dilution). My hope is that we not only get re-rated and approximate these peers, but that we leap frog them altogether! Which means we are potentially looking at 40-50X in a canter.....Just saying!!
- Forums
- ASX - By Stock
- Comparative Analysis
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Tweaked the format of the comparison and added Race...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $100 | 25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 19510638 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.004 |
37 | 23631939 | 0.003 |
15 | 13500507 | 0.002 |
9 | 49600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 19510638 | 27 |
0.006 | 23500718 | 17 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
0.009 | 2767672 | 5 |
Last trade - 15.25pm 17/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online